GLP-1RAs, which achieved great success in 2023 and draws peoples attention back to obesity treatments and GLP-1 therapies worldwide, was chosen as the breakthrough of year 2023 by Science [2]
db/db mice (The Jackson Laboratory, 000697) were kept on a chow diet (Brogaarden, Altromin, 1310) and experiments were conducted on 9-week-old male mice
At the same time, clinicians are getting a clearer sense of the side effects, mild and severe
Improved Metabolic Health In addition to weight loss, GLP-1 medications may help improve several metabolic health markers, including: Blood sugar levels HbA1c Blood pressure Triglycerides These benefits may be especially valuable for patients managing pre-diabetes or metabolic syndrome
Voltage-gated calcium channels
Interestingly, recent trials have shown that tirzepatide is more effective than semaglutide